Jung 2014.

Trial name or title	Effect of Dexmedetomidine on Recovery Profiles of Elderly Patients
Methods	RCT, 4 parallel groups
Participants	Number: 120 participants, both genders Country: Korea Surgery: not stated, elective Age: > 65 years ASA: I to II Other inclusion criteria: not stated Exclusion criteria: severe heart disease (New York Heart Association class > III, severe arrhythmia, uncontrolled hypertension or hypotension, hypersensitivity to drugs, cognitive deficiency, dementia or delirium, hepatic or renal impairment, infective disease
Interventions	General anaesthesia with sevoflurane (n = 30) vs General anaesthesia with propofol and remifentanil (n = 30) vs General anaesthesia with sevoflurane. Infusion of dexmedetomidine (0.4 μg/kg/h) during anaesthesia (n = 30) vs General anaesthesia with propofol and remifentanil. Infusion of dexmedetomidine (0.4 μg/kg/h) during surgery (n = 30)
Outcomes	Recovery characteristics (time to recovery of consciousness (ROC) and recovery) Bispectral index (BIS) values at ROC and orientation Ricker sedation‐agitated scale at the postanaesthetic care unit Safety (vital signs during and after administration of dexmedetomidine)
Starting date	May 2013
Contact information	Study Chair: Ki Tae Jung, MD, Department of Anesthesiology and Pain Medicine, School of Medicine, Chosun University, Gwangju, Korea, 501‐717
Notes	Status at clinicaltrials.gov: completed, last verified March 2014, no results posted Clinical Trials identifier: NCT01851005 Type of surgery not stated ‐ might not be abdominal surgery